C-Reactive Protein Gene Variants in Depressive Symptoms & Antidepressants Efficacy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Although the pathogenesis of depression remains unclear, C-reactive protein (CRP) levels are commonly elevated in depressed patients. Thus, CRP single-nucleotide polymorphisms (SNPs) that influence CRP levels may be associated with depression. In the present study, we explored whether CRP SNPs are related to depressive symptoms and antidepressants efficacy in Han Chinese patients. Methods We analyzed data from 440 patients with first-episode depression. We obtained genome CRP SNPs, scores of the 17-item Hamilton Rating Scale for Depression 17 (HAMD17) and its four-factor at baseline and after 6 weeks. Quantitative trait analysis was performed using UNPHASED software and curative effects were analyzed using SPSS software. Results Male patients with SNP rs1800947G exhibited lower insomnia scores and rs2794521CC exhibited lower scores of anxiety/ physical symptoms, total HAMD17 score. Female patients with rs2794521TT exhibited higher scores of insomnia and lower antidepressants efficacy. Conclusion CRP SNPs rs1800947 and rs2794521 may be associated with depressive symptoms in patients with depression in a sex-specific fashion. Furthermore, rs2794521 may be a predictor of the efficacy of antidepressants in female patients.
Abstract
Objective Although the pathogenesis of depression remains unclear, C-reactive protein (CRP) levels are commonly elevated in depressed patients. Thus, CRP single-nucleotide polymorphisms (SNPs) that influence CRP levels may be associated with depression. In the present study, we explored whether CRP SNPs are related to depressive symptoms and antidepressants efficacy in Han Chinese patients. Methods We analyzed data from 440 patients with first-episode depression. We obtained genome CRP SNPs, scores of the 17-item Hamilton Rating Scale for Depression 17 (HAMD17) and its four-factor at baseline and after 6 weeks. Quantitative trait analysis was performed using UNPHASED software and curative effects were analyzed using SPSS software. Results Male patients with SNP rs1800947G exhibited lower insomnia scores and rs2794521CC exhibited lower scores of anxiety/ physical symptoms, total HAMD17 score. Female patients with rs2794521TT exhibited higher scores of insomnia and lower antidepressants efficacy. Conclusion CRP SNPs rs1800947 and rs2794521 may be associated with depressive symptoms in patients with depression in a sex-specific fashion. Furthermore, rs2794521 may be a predictor of the efficacy of antidepressants in female patients.
참고문헌 (40)
- Sumiyoshi T, "Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder in Japan(PERFORM-J) : protocol for a prospective cohort study", JMIR Res Protoc, 7, pp.e161~ (2018)
- Kohler CA, "Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder : systematic review and meta-analysis", Mol Neurobiol, 55, pp.4195~4206 (2018)
- Ma L, "Animal inflammation-based models of depression and their application to drug discovery", Expert Opin Drug Discov, 12, pp.995~1009 (2017)
- Lopresti AL, "Cognitive behaviour therapy and inflammation : a systematic review of its relationship and the potential implications for the treatment of depression", Aust N Z J Psychiatry, 51, pp.565~582 (2017)
- Horn SR, "Replication and reproducibility issues in the relationship between C-reactive protein and depression : a systematic review and focused metaanalysis", Brain Behav Immun, 73, pp.85~114 (2018)
- Felger JC, "What does plasma CRP tell us about peripheral and central inflammation in depression?", Mol Psychiatry (2018)
- Chang HH, "C-reactive protein : a differential biomarker for major depressive disorder and bipolar II disorder", World J Biol Psychiatry, 18, pp.63~70 (2017)
- Strawbridge R, "Inflammation and clinical response to treatment in, depression : a meta-analysis", Eur Neuropsychopharmacol, 25, pp.1532~1543 (2015)
- Haapakoski R, "Cumulative meta-analysis of interleukins 6 and 1 beta, tumour necrosis factor alpha and C-reactive protein in patients with, major depressive disorder", Brain Behavior Immun, 49, pp.206~215 (2015)
- Tayefi M, "Depression and anxiety both associate with serum level of hs-CRP : a gender-stratified analysis in a population-based study", Psychoneuroendocrinology, 81, pp.63~69 (2017)
- Xia QR, "Increased plasma nesfatin-1 levels may be associated with corticosterone, IL-6, and CRP levels in patients with major depressive disorder", Clin Chim Acta, 480, pp.107~111 (2018)
- 허남욱, "Is the Relationship between Depression and C Reactive Protein Level Moderated by Social Support in Elderly?-Korean Social Life, Health, and Aging Project (KSHAP)", PSYCHIATRY INVESTIGATION, 15(1), pp.24~33 (2018), 대한신경정신의학회[DOI]
- Chang HH, "Treatment response and cognitive impairment in major depression : association with C-reactive protein", Brain Behav Immun, 26, pp.90~95 (2012)
- Krogh J, "The association between depressive symptoms, cognitive function, and inflammation in major depression", Brain Behavior Immun, 35, pp.70~76 (2014)
- Valkanova V, "CRP, IL-6 and depression : a systematic review and meta-analysis of longitudinal studies", J Affect Disord, 150, pp.736~744 (2013)
- Uher R, "An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline", Am J Psychiatry, 171, pp.1278~1286 (2014)
- Miller ES, "The association of serum C-reactive protein with the occurrence and course of postpartum depression", Arch Womens Ment Health, 22, pp.129~132 (2019)
- Tayefi M, "hs-CRP is strongly associated with coronary heart disease(CHD) : a data mining approach using decision tree algorithm", Comput Methods Programs Biomed, 141, pp.105~109 (2017)
- Ancelin ML, "C-reactive protein gene variants : independent association with late-life depression and circulating protein levels", Transl Psychiatry, 5, pp.e499~ (2015)
- Kettunen T, "Polymorphism in the C-reactive protein(CRP)gene affects CRP levels in plasma and one early marker of atherosclerosis in men : the Health 2000 Survey", Scand J Clin Lab Invest, 71, pp.353~361 (2011)
- Su S, "Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men : the Twins Heart Study", Psychosom Med, 71, pp.152~158 (2009)
- Gaysina D, "Association between adolescent emotional problems and metabolic syndrome : the modifying effect of C-reactive protein gene(CRP)polymorphisms", Brain Behavior Immun, 25, pp.750~758 (2011)
- Halder I, "Polymorphisms in the CRP gene moderate an association between depressive symptoms and circulating levels of C-reactive protein", Brain Behav Immun, 24, pp.160~167 (2010)
- Luciano M, "Association of existing and new candidate genes for anxiety, depression and personality traits in older people", Behav Genet, 40, pp.518~532 (2010)
- Mittal VA, "Diagnostic and statistical manual of mental disorders", Psychiatry Res, 189, pp.158~159 (2011)
- Suchankova P, "Genetic variability within the innate immune system influences personality traits in women", Genes Brain Behav, 8, pp.212~217 (2009)
- Kittel-Schneider S, "CRP genetic variants are associated with mortality and depressive symptoms in chronic heart failure patients", Brain Behav Immun, 71, pp.133~141 (2018)
- Cubala WJ, "C-reactive protein and cortisol in drug-naive patients with short-illness-duration first episode major depressive disorder: possible role of cortisol immunomodulatory action at early stage of the disease", J Affect Disord, 152–154, pp.534~537 (2014)
- Cubala WJ, "Magnesium, C-reactive protein, and cortisol in drug-naive patients with short illness-duration, first episode major depressive disorder : possible immunomodulatory role for magnesium", Magnes Res, 29, pp.169~174 (2016)
- Verduijn J, "Pathophysiology of major depressive disorder : mechanisms involved in etiology are not associated with clinical progression", Transl Psychiatry, 5, pp.e649~ (2015)
- Pavon L, "Th2 cytokine response in Major Depressive Disorder patients before treatment", J Neuroimmunol, 172, pp.156~165 (2006)
- McQuade R, "Future therapeutic targets in mood disorders : the glucocorticoid receptor", Br J Psychiatry, 177, pp.390~395 (2000)
- Cowen PJ, "Cortisol, serotonin and depression: all stressed out?", Br J Psychiatry, 180, pp.99~100 (2002)
- Rossi R, "Effects of progestins on estrogen-induced increase in C-reactive protein in postmenopausal women", Maturitas, 49, pp.315~320 (2004)
- Ryan J, "Lifetime hormonal factors may predict late-life depression in women", Int Psychogeriatr, 20, pp.1203~1218 (2008)
- Skouby SO, "Hormone replacement therapy : estrogen and progestin effects on plasma C-reactive protein concentrations", Am J Obstet Gynecol, 186, pp.969~977 (2002)
- Chrousos GP, "Stress and sex versus immunity and inflammation", Sci Signal, 3, pp.pe36~ (2010)
- Kumsta R, "Sex specific associations between common glucocorticoid receptor gene variants and hypothalamus-pituitary-adrenal axis responses to psychosocial stress", Biol Psychiatry, 62, pp.863~869 (2007)
- Handa RJ, "Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis", Front Neuroendocrinol, 35, pp.197~220 (2014)
- Suarez EC, "Depressogenic vulnerability and gender-specific patterns of neuro-immune dysregulation : what the ratio of cortisol to C-reactive protein can tell us about loss of normal regulatory control", Brain Behav Immun, 44, pp.137~147 (2015)